Nuclear Medicine
Investigators at National Chung-Hsing University, Department of Veterinary Medicine publish new data on nuclear medicine
Published in Biotech Business Week, April 2nd, 2007
New investigation results, "Reducing renal uptake of 111In-DOTATOC: a comparison among various basic amino acids," are detailed in a study published in Annals of Nuclear Medicine. According to recent research from Taichung, Taiwan, "Several studies have reported significant renal toxicity after the use of a high dose of 90Y-DOTATOC. Thus, renal protection is necessary in treatments with 90Y-DOTA Tyr3-octreotide (DOTATOC)."
"The infusion of certain positively charged amino acids has been shown to effectively reduce renal uptake of DOTATOC. In this study, we compared the effectiveness of three kinds of amino acids, D-lysine (lysine), L-arginine (arginine) and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Alzheimer Disease
Scientists discover zinc link to a leading cause of blindness - Blindness
Glaucoma diagnosis may be mistaken in some younger Chinese people - Breast Cancer
UBC discovery may lead to 'smart' therapies for breast, ovarian cancer - Cancer
Morphine kills pain -- not patients - Cancer
Small molecule derived from Rb2/p130 could act as cancer therapeutic - Carcinoma
Sutent achieves first line EAU approval for kidney cancer - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
